Clinical Trial

Epidemiology of Antimicrobial-use and Antimicrobial-resistant Infections in Four Hospitals in Thailand

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The main goal of this retrospective observational study is to understand how stepping down antibiotic treatment (called antibiotic de-escalation) affects patients who receive it compared to those who don't after received a short-course (≤7 days) of parenteral antibiotics. The investigators will use past medical records from four public referral hospitals in Thailand from the year 2019 to 2024. The investigators will firstly evaluate which types of patients are more likely to receive antibiotic de-escalation. Then, the investigators will estimate the impact of antibiotic de-escalation, while taking those differences into account. This way, it will help us understand the impact of antibiotic de-escalation in real-world clinical practice. The investigators also aim to assess how accurate automated outbreak detection systems are at detecting outbreaks, evaluate patterns of antimicrobial use and antimicrobial-resistant infections, and develop new indicators for antimicrobial stewardship that are applicable for local and national actions in low and middle-income countries.
Protocol Amendment History 3 changes
critical Trial status changed: Not Yet Recruiting → Active, Not Recruiting 2026-08-15
notable Primary completion moved earlier: 2026-08-16 -> 2026-06-30 2026-08-15
minor Completion pushed: 2026-08-16 -> 2027-11-30 2026-08-15
Trial Details
NCT Number NCT07082465
Lead Sponsor University of Oxford
Collaborators: Wellcome Trust
Conditions Drug Resistance, Bacterial, Bacteremia
Enrollment 108,000 participants
Start Date 2025-12-01
Primary Completion 2026-06-30 (estimated)
Study Completion 2027-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-14